A business in context
EYPT research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-08-20 | Elston George | J · Other (see filing) | Common Stock | 5000.0 | 0.0 |
| 2026-08-20 | Elston George | J · Other (see filing) | Common Stock | 5000.0 | 0.0 |
| 2026-08-20 | Elston George | G · Gift | Common Stock | 64953.0 | 0.0 |
| 2026-08-20 | Elston George | G · Gift | Common Stock | 64953.0 | 0.0 |
| 2026-08-18 | Zaderej Karen L. | P · Purchase | Common Stock | 10600.0 | 4.93 |
| 2026-07-10 | Duker Jay S. | M · Exercise / conversion | Common Stock | 16667.0 | 0.0 |
| 2026-07-10 | Duker Jay S. | F · Tax / exercise payment | Common Stock | 8059.0 | 14.72 |
| 2026-07-10 | Duker Jay S. | M · Exercise / conversion | Restricted Stock Units | 16667.0 | 0.0 |
| 2026-06-30 | Ribeiro Ramiro | M · Exercise / conversion | Common Stock | 2437.0 | 8.26 |
| 2026-06-30 | Ribeiro Ramiro | S · Sale | Common Stock | 2438.0 | 15.02 |
| 2026-06-30 | Ribeiro Ramiro | S · Sale | Common Stock | 2437.0 | 15.0 |
| 2026-06-30 | Ribeiro Ramiro | M · Exercise / conversion | Common Stock | 2438.0 | 8.26 |
| 2026-06-30 | Ribeiro Ramiro | M · Exercise / conversion | Stock Option (Right to Buy) | 2437.0 | 0.0 |
| 2026-06-30 | Ribeiro Ramiro | M · Exercise / conversion | Stock Option (Right to Buy) | 2438.0 | 0.0 |
Identity & relationships
SEC issuer · 0001314102EyePoint, Inc.
pSivida
- Legal Entity Identifier
- 549300QE1RU34T50MR69
- GLEIF legal name
- EYEPOINT, INC.
- Entity / LEI registration status
- ACTIVE / ISSUED
- Reference data updated
- 2025-12-19T16:18:01Z
Search names and former names
View Wikidata identity and references ↗
- EyePoint Pharmaceuticals · alias · wikidata
- pSivida Corp. · alias · wikidata
- pSivida · subsidiary · wikidata
- EyePoint Pharmaceuticals (United Kingdom) · subsidiary · wikidata
- EyePoint Pharmaceuticals, Inc. · former SEC name · 2018-04-02 to 2025-12-08
- pSivida Corp. · former SEC name · 2008-06-19 to 2018-03-30
- pSivida LTD · former SEC name · 2005-01-20 to 2008-06-18
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $43.27M | $46.48M |
| 2023-12-31 | $46.02M | $50.88M |
| 2022-12-31 | $41.40M | $47.66M |
| 2021-12-31 | $36.94M | $45.92M |
| 2020-12-31 | $34.44M | $44.83M |
| 2019-12-31 | $20.36M | $26.84M |
| 2018-12-31 | $4.57M | $6.13M |